Please login to the form below

Not currently logged in
Email:
Password:

Regeneron

This page shows the latest Regeneron news and features for those working in and with pharma, biotech and healthcare.

Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV

Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV

Regeneron has ended four clinical trials of its monoclonal antibody combination, REGEN-COV (casirivimab and imdevimab), according to the federal clinical trial database. ... Regeneron invented the antibody cocktail and is collaborating with Roche, the

Latest news

More from news
Approximately 98 fully matching, plus 188 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    The same approach may work against SARSCoV-2. Regeneron Pharmaceuticals, leveraging a platform that spawned an Ebola treatment, is leading efforts to show that antibodies can neutralise SARS-CoV-2. ... A clinical trial of Regeneron’s drug is scheduled

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... 19,” said George D Yancopoulos, co-founder,

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    The changes also mean Sanofi has downgraded some long-standing relationship in R&D – such as a fruitful tie-up with Regeneron that generated some of its top-selling drugs like ... Analysts think the deal could catapult Galapagos into the top tier of

  • Case study: See Below Case study: See Below

    Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.

More from intelligence
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest appointments

  • Tiziana Life Sciences appoints clinical sciences VP Tiziana Life Sciences appoints clinical sciences VP

    Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson &Johnson and Regeneron.

  • Regeneron taps Pfizer for CFO Regeneron taps Pfizer for CFO

    Robert Landry succeeds Murray Goldberg. Former Pfizer senior VP Robert Landry has joined Regeneron as senior VP, finance, and will later take over as chief financial officer. ... We are extremely fortunate that Murray will stay at Regeneron through 2014

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...